Evidence map›Paper›PMID 30625475›Full record

ArticleNeuroimmunomodulation2019

Characterization of the Hippocampal Neuroimmune Response to Binge-Like Ethanol Consumption in the Drinking in the Dark Model.

Isabella R Grifasi, Scot E McIntosh, Rhiannon D Thomas, Donald T Lysle, Todd E Thiele, S Alex Marshall

Open access · greenAbstract read
In one paragraph

Article in Neuroimmunomodulation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. MAO-B status in alcohol use disorder: a [Molecular psychiatry · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Isabella R GrifasiDepartment of Basic Pharmaceutical Sciences, Fred P. Wilson School of Pharmacy, High Point University, High Point, North Carolina, USA.
Scot E McIntoshDepartment of Basic Pharmaceutical Sciences, Fred P. Wilson School of Pharmacy, High Point University, High Point, North Carolina, USA.
Rhiannon D ThomasDepartment of Psychology and Neuroscience, The University of North Carolina, Chapel Hill, North Carolina, USA.
Donald T LysleDepartment of Psychology and Neuroscience, The University of North Carolina, Chapel Hill, North Carolina, USA.
Todd E ThieleDepartment of Psychology and Neuroscience, The University of North Carolina, Chapel Hill, North Carolina, USA.
S Alex MarshallDepartment of Basic Pharmaceutical Sciences, Fred P. Wilson School of Pharmacy, High Point University, High Point, North Carolina, USA, simon.alexm@highpoint.edu.
University of North Carolina at Chapel Hill · USHigh Point University · US

Funding

UNC ARC Information/Dissemination CoreP60AA011605 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Clyde W Hodge · 2003 to 2026
$46.3M
SEEDING POSTDOCTORAL INNOVATORS IN RESEARCH &EDUCATIONK12GM000678 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DONALD T LYSLE, Kathryn Joanna Reissner · 1999 to 2026
$30.9M
MOLECULAR AND CELLULAR PATHOGENESIS IN ALCOHOLISMP50AA011605 · NIAAA · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI SAMULSKI, RICHARD J · 1998 to 2002
$4.9M
Training in Drug Abuse Related Research.T32DA016176 · NIDA · UNIVERSITY OF KENTUCKY · PI DWOSKIN, LINDA P · 2004 to 2020
$4.0M
The role of corticotropin releasing factor in binge-like ethanol drinkingR01AA022048 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Thomas L. Kash, TODD Eric THIELE · 2013 to 2026
$3.2M
Neuropeptide Y: Role in Ethanol Intake and SensitivityR37AA013573 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TODD Eric THIELE · 2019 to 2026
$3.0M
NIAAA NIH HHS P50 AA011605NIAAA NIH HHS P60 AA011605NIAAA NIH HHS R01 AA022048NIAAA NIH HHS R37 AA013573NIDA NIH HHS T32 DA016176NIGMS NIH HHS K12 GM000678
6 · The paper itself

Abstract

objectivesAlcohol dependence leads to dysregulation of the neuroimmune system, but the effects of excessive alcohol consumption on key players of the neuroimmune response after episodic binge drinking in nondependence has not been readily assessed. These studies seek to determine how the neuroimmune system within the hippocampus responds to binge-like consumption prior to dependence or evidence of brain damage.

methodsC57BL/6J mice underwent the drinking in the dark (DID) paradigm to recapitulate binge consumption. Immunohistochemical techniques were employed to determine the effects of ethanol on cytokine and astrocyte responses within the hippocampus. Astrocyte activation was also assessed using qRT-PCR.

resultsOur results indicated that binge-like ethanol consumption resulted in a 3.6-fold increase in the proinflammatory cytokine interleukin (IL)-1β immunoreactivity in various regions of the hippocampus. The opposite effect was seen in the anti-inflammatory cytokine IL-10. Binge-like consumption resulted in a 67% decrease in IL-10 immunoreactivity but had no effect on IL-4 or IL-6 compared with the water-drinking control group. Moreover, astrocyte activation occurred following ethanol exposure as GFAP immunoreactivity was increased over 120% in mice that experienced 3 cycles of ethanol binges. PCR analyses indicated that the mRNA increased by almost 4-fold after one cycle of DID, but this effect did not persist in abstinence.

conclusionsAltogether, these findings suggest that binge-like ethanol drinking prior to dependence causes dysregulation to the neuroimmune system. This altered neuroimmune state may have an impact on behavior but could also result in a heightened neuroimmune response that is exacerbated from further ethanol exposure or other immune-modulating events.

Indexed as

AnimalsBinge DrinkingCentral Nervous System DepressantsEthanolGlial Fibrillary Acidic ProteinHippocampusImmunohistochemistryInterleukin-10Interleukin-1betaInterleukin-4Interleukin-6MaleMiceRNA, MessengerCentral Nervous System DepressantsEthanolGlial Fibrillary Acidic ProteinIL10 protein, mouseIL1B protein, mouseIl4 protein, mouseInterleukin-10Interleukin-1betaInterleukin-4Interleukin-6interleukin-6, mouseRNA, MessengerAlcohol abuseAstrocyte activationBinge drinkingCytokineHippocampusNeuroimmune

Identifiers

PMID30625475
PMCPMC6389401
OpenAlexW2909150304

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.